View the BCYC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bicycle Therapeutics. Stock analysis for Bicycle Therapeutics PLC (BCYC:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Get the latest updates on Bicycle Therapeutics plc American Depositary Shares (BCYC) pre market trades, share volumes, and more Stock prices may also. View the BCYC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bicycle Therapeutics. About Bicycle Therapeutics plc American Depositary Shares (BCYC) ; CEO: Kevin Lee ; Founded: ; Employees: ; Sector: Healthcare ; Industry: Biotechnology.
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year Financial Results. CAMBRIDGE, England & BOSTON--(BUSINESS WIRE) Bicycle Therapeutics plc is currently listed on NASDAQ under BCYC. One share of BCYC stock can currently be purchased for approximately $ Is. Bicycle Therapeutics shares fall 23% after the company shares interim Phase 1 data. Shares of Bicycle Therapeutics Inc. tumbled % in premarket trading. Bicycle Therapeutics plc (symbol: BCYC) is a pioneering clinical-stage biotechnology company with a mission to transform the pharmaceutical industry. Discover all the factors affecting Bicycle Therapeutics's share price. BCYC is currently rated as a Neutral | Stockopedia. On average, Wall Street analysts predict that Bicycle Therapeutics's share price could reach $ by Aug 7, The average Bicycle Therapeutics stock price. Discover real-time Bicycle Therapeutics plc American Depositary Shares (BCYC) stock prices, quotes, historical data, news, and Insights for informed trading. Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines. Get Bicycle Therapeutics PLC (BCYC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines. Press Releases · Overview · Stock Information · SEC Filings · Annual General Meeting · UK Annual Reports · Governance + Leadership · Presentation + Events · Analyst.
Bicycle Therapeutics plc ; Open. ; High. ; 52wk High. ; Volume. 6, ; Beta. Find the latest Bicycle Therapeutics plc (BCYC) stock quote, history, news and other vital information to help you with your stock trading and investing. The Investor Relations website contains information about Bicycle Therapeutics's business for stockholders, potential investors, and financial analysts. Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles. Key statistics. On Thursday, Bicycle Therapeutics PLC (BCYC:NSQ) closed at , % below its week high of , set on Feb 28, What is Bicycle Therapeutics PLC(BCYC)'s stock price today? The current price of BCYC is $ The 52 week high of BCYC is $ and 52 week low is $ Real time Bicycle Therapeutics Plc (BCYC) stock price quote, stock graph, news & analysis. Key Stats · Market CapB · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Which stock exchange are Bicycle Therapeutics American Depositary Shares (“ADSs”) traded on and what is the company's ticker? Expand. Bicycle Therapeutics is.
Current stock price for Bicycle Therapeutics (BCYC)?. A. The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $ last updated Today at August 7, The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Bicycle Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BCYC. The last closing price for Bicycle Therapeutics was. Bicycle Therapeutics plc ; Open. ; High. ; 52wk High. ; Volume. 6, ; Beta. Stock analysis for Bicycle Therapeutics PLC (BCYC:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company.
Stock/Option, Shares, Shares Change, Price, Cost, Final Share. Anna Hannah. Chief Executive Officer. 01/01/ Sell. Option. K. %. $ $,
What Can Help Your Credit Score | Experian Identity Works Review